Neoprofen Solution
Product Images NDC 55292-122

2 FDA label images from Recordati Rare Diseases Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Neoprofen (NDC 55292-122). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Recordati Rare Diseases Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

3vialcarton (3vialcarton)

3vialcarton (3vialcarton)
Label for NeoProfen (ibuprofen lysine) injection 20 mg/2 mL (10 mg/mL) sterile solution for intravenous use. Packaging indicates 3 x 2 mL single-use vials. Labeler is Recordati Rare Diseases Inc., with manufacturing by Alcami Carolinas Corporation. Includes storage instructions, GTIN, lot number, and expiration date fields.*
FDA Label Image

Neoprofen 01

Neoprofen 01
Chemical structure diagram depicting the molecular formula of ibuprofen lysine, the active ingredient in NEOPROFEN 10 mg/mL intravenous solution by Recordati Rare Diseases Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.